🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 20 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/04/1986 | 4,65 | 4,70 | 4,65 | 4,66 | +0,93% | 1,21% | 15.430.752 |
| 31/03/1986 | 4,53 | 4,64 | 4,51 | 4,62 | +2,65% | 2,85% | 10.062.058 |
| 27/03/1986 | 4,53 | 4,69 | 4,48 | 4,50 | +1,34% | 4,68% | 18.230.170 |
| 26/03/1986 | 4,31 | 4,44 | 4,31 | 4,44 | +3,96% | 3,08% | 8.560.483 |
| 25/03/1986 | 4,26 | 4,35 | 4,24 | 4,27 | +0,70% | 2,49% | 10.129.968 |
| 24/03/1986 | 4,28 | 4,29 | 4,21 | 4,24 | -0,77% | 1,86% | 6.934.406 |
| 21/03/1986 | 4,41 | 4,43 | 4,27 | 4,27 | -2,86% | 3,61% | 17.939.664 |
| 20/03/1986 | 4,32 | 4,45 | 4,32 | 4,40 | +2,95% | 3,15% | 9.703.642 |
| 19/03/1986 | 4,25 | 4,31 | 4,21 | 4,27 | +1,02% | 2,18% | 4.889.549 |
| 18/03/1986 | 4,21 | 4,28 | 4,19 | 4,23 | +0,08% | 2,12% | 7.813.469 |
| 17/03/1986 | 4,26 | 4,28 | 4,22 | 4,23 | -1,32% | 1,24% | 7.836.106 |
| 14/03/1986 | 4,15 | 4,29 | 4,12 | 4,28 | +4,27% | 4,23% | 14.604.509 |
| 13/03/1986 | 4,11 | 4,16 | 4,10 | 4,11 | -0,32% | 1,53% | 10.620.432 |
| 12/03/1986 | 4,09 | 4,18 | 4,09 | 4,12 | +1,30% | 2,35% | 10.428.019 |
| 11/03/1986 | 4,01 | 4,10 | 4,00 | 4,07 | +1,74% | 2,48% | 6.262.848 |
| 10/03/1986 | 3,99 | 4,00 | 3,98 | 4,00 | +0,08% | 0,66% | 3.169.152 |
| 07/03/1986 | 3,92 | 4,02 | 3,92 | 4,00 | +2,20% | 2,53% | 7.160.774 |
| 06/03/1986 | 3,91 | 3,92 | 3,89 | 3,91 | +0,43% | 0,85% | 6.930.634 |
| 05/03/1986 | 3,94 | 3,94 | 3,88 | 3,89 | -1,09% | 1,52% | 6.998.544 |
| 04/03/1986 | 3,96 | 4,01 | 3,93 | 3,94 | -0,50% | 2,10% | 5.961.024 |
| 03/03/1986 | 3,96 | 3,99 | 3,94 | 3,96 | -0,91% | 1,25% | 5.764.838 |
| 28/02/1986 | 4,05 | 4,05 | 3,99 | 3,99 | -1,23% | 1,64% | 5.700.701 |
| 27/02/1986 | 3,99 | 4,11 | 3,95 | 4,04 | +1,24% | 3,91% | 8.994.355 |
| 26/02/1986 | 3,99 | 4,03 | 3,96 | 3,99 | -0,08% | 1,58% | 6.749.539 |
| 25/02/1986 | 4,00 | 4,02 | 3,97 | 4,00 | -0,33% | 1,32% | 5.214.010 |
| 24/02/1986 | 4,04 | 4,04 | 4,00 | 4,01 | -0,82% | 1,15% | 7.798.378 |
| 21/02/1986 | 4,01 | 4,04 | 3,92 | 4,04 | +1,41% | 2,97% | 13.865.040 |
| 20/02/1986 | 3,91 | 3,99 | 3,89 | 3,99 | +1,61% | 2,54% | 5.564.880 |
| 19/02/1986 | 3,90 | 3,98 | 3,89 | 3,92 | +0,51% | 2,12% | 6.560.899 |
| 18/02/1986 | 3,83 | 3,90 | 3,79 | 3,90 | +2,26% | 2,86% | 6.741.994 |